export const signalData =
[
  {
    'title': 'Cover Page',
    'id': '0',
    'data': '<p><strong>SIGNAL EVALUATION REPORT</strong></p><p><strong>&nbsp;</strong></p><table border=\'1’><tbody><tr><td width=\'301’><p><strong>PRODUCT&reg; / project</strong></p></td><td width=\'301’><p>&nbsp;</p></td></tr><tr><td width=\'301’><p><strong>SUBJECT or EVENT</strong></p></td><td width=\'301’><p>&nbsp;</p></td></tr><tr><td width=\'301’><p><strong>Author(s):</strong></p></td><td width=\'301’><p>&nbsp;</p></td></tr><tr><td width=\'301’><p><strong>Date:</strong></p></td><td width=\'301’><p>&nbsp;</p></td></tr><tr><td width=\'301’><p><strong>Status</strong></p></td><td width=\'301’><p>[Draft or Final]</p></td></tr></tbody></table><p>&nbsp;</p><p><span style=\'color: #ff0000;’><em>Throughout the document, text in red/italics provides instructions for completion of the document and should be deleted prior to its finalization. </em></span></p><p><span style=\'color: #ff0000;’><em>Other text provides suggested wording for the content of the document covering various scenarios and can be modified/deleted as appropriate.</em></span></p>'
  },
  {
    'title': 'Executive Summary',
    'id': '1',
    'data': '<p>if appropriate.</p>'
  },
  {
    'title': 'Source of the signal',
    'id': '2',
    'data': '<p><span style=\'color: #ff0000;\'>Provide here (as appropriate) information on why is this document written (i. e. purpose, source of the signal).</span></p><p>The objective of this document is to review [specify here what the document intends to achieve.]</p><p>or</p><p>The present document is written in response to a request from [insert here source of the request] dated DD-MMM-YYYY to [specify here what the request is].</p>'
  },
  {
    'title': 'Background relevant to the evaluation',
    'id': '3',
    'data': '<p>XX is a [<em>provide here a very brief introduction on the product, its&nbsp; mode of action, and the indication(s) (whenever available refer to existing documents such as SmPC or USPI for details</em>)]. Further information on its indication(s), its mode of action as well as its main characteristics can be obtained in the SmPC dated dd-Mmm-yyyy [reference].</p><p>&nbsp;</p><p>XX is indicated in [<em>provide here a very brief introductory summary of the disease area under discussion. This section is not always necessary</em>].</p><p>XX is currently marketed in &hellip;.</p><p><span style=\'color: #ff0000;’><em>Provide information on patient exposure, including the assumptions and the data used. </em></span></p><p><span style=\'color: #ff0000;’><em>Provide the (brief) medical (pathophysiology, etiology) and epidemiological (incidence of event in general or relevant population) background on the events to be analyzed. If available and useful, provide here drug utilization patterns and typical comorbidities of the relevant patient population.</em></span></p><p><span style=\'color: #ff0000;’><em>Mention whether the event(s) covered are listed in reference safety documents and whether they have been previously evaluated.</em></span></p>'
  },
  {
    'title': 'Methods of evaluation',
    'id': '4',
    'data': '<p><span style=\'color: #ff0000;’><em>Provide here a brief description of the sources of information used to achieve the purpose of the document, any search strategy, or analytical approaches.</em></span></p>'
  },
  {
    'title': 'Cases / events from the GVS database',
    'id': '4.1',
    'data': '<p>The GVS database was searched since product\'s launch [<em>or any date, as appropriate</em>] with data lock point of [<em>dd-MMM-yyyy</em>].</p><p>The search strategy included the following terms from MedDRA dictionary Version [<em>n</em>:]: HLT [<em>list terms]</em>, PT <em>[list terms],</em> SMQ <em>(<span style=\'color: #ff0000;’>indicate whether broad or narrow search, any terms that were added or deleted and why</span>).</em></p><p>This search includes unsolicited serious and non-serious adverse event reports irrespective of causality or type of reporter and solicited serious adverse events from clinical studies <em><span style=\'color: #ff0000;’>(adapt as needed, consider to present clinical trial data separately below</span>).</em></p><p><span style=\'color: #ff0000;’><em>Describe any filtering methods that you plan to use later (e.g. case definitions, exclusion of biases, exclusion of poorly documented cases, confounders).</em></span></p><p>The case summaries are presented in line listings in Appendix x of this document.</p>'
  },
  {
    'title': 'Clinical data',
    'id': '4.2',
    'data': '<p><span style=\'color: #ff0000;’><em>Provide here a brief description of the other sources of information used to achieve the purpose of the document (e.g. recently completed studies, pooled clinical data, post-marketing safety studies).</em></span></p><p><span style=\'color: #ff0000;’><em>Details the results.</em></span></p>'
  },
  {
    'title': 'Literature',
    'id': '4.3',
    'data': '<p><span style=\'color: #ff0000;’><em>Provide a brief description of the literature search used to achieve the purpose of the document: indicate database (s), date of search, period covered by the search, and search strategy used (keywords, MeSH terms, Boolan connectors [AND, OR, NOT] etc</em><em>). </em></span></p><p><span style=\'color: #ff0000;’><em>For \'Internet-based databases, indicate the www address at which the database was accessed and date.</em></span></p>'
  },
  {
    'title': 'Epidemiological studies',
    'id': '4.4',
    'data': '<p><span style=\'color: #ff0000;’><em>If applicable, mention any epidemiological data used for the analysis.</em></span></p>'
  },
  {
    'title': '[Others]',
    'id': '4.5',
    'data': '<p><span style=\'color: #ff0000;’><em>Provide here a brief description of the other sources of information used to achieve the purpose of the document.</em></span></p><p><span style=\'color: #ff0000;’><em>Examples: </em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Authorities databases</em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Pharmacological class</em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non clinical data</em></span></p>'
  },
  {
    'title': 'Results',
    'id': '5',
    'data': '<p><span style=\'color: #ff0000;’>When multiple drugs/topics are covered, create subsections as appropriate.</span></p><p><span style=\'color: #ff0000;’><em>Summarize your findings organized by the source of information, e.g. results of the NSH safety database, literature, epidemiology, other sources.</em></span></p><p><span style=\'color: #ff0000;’><em>Use tables as much as possible. Avoid to repeat the content of the tables in the text.</em></span></p>'
  },
  {
    'title': 'Cases / events from NSH safety database',
    'id': '5.1',
    'data': '<p><span style=\'color: #ff0000;’><em>Use tables as much as possible. Provide the number of cases retrieved. </em></span></p><p><span style=\'color: #ff0000;’><em>Explain which cases were included in the analysis and explain why reports were excluded from the analysis. &nbsp;</em></span></p><p><span style=\'color: #ff0000;’><em>Example</em></span></p><table border=\'1’><tbody><tr><td width=\'425’><p><span style=\'color: #ff0000;’><em>Number of cases retrieved</em></span></p></td><td width=\'101’><p><span style=\'color: #ff0000;’><em>N1</em></span></p></td></tr><tr><td width=\'425’><p><span style=\'color: #ff0000;’><em>Number of cases excluded from the analysis (e.g. too limited information)</em></span></p></td><td width=\'101’><p><span style=\'color: #ff0000;’><em>N2</em></span></p></td></tr><tr><td width=\'425’><p><span style=\'color: #ff0000;’><em>Cases with likely alternative explanation (provide case IDs and reasons for exclusion in an Appendix)</em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;</em></span></p></td><td width=\'101’><p><span style=\'color: #ff0000;’><em>N3</em></span></p></td></tr><tr><td width=\'425’><p><span style=\'color: #ff0000;’><em>Cases retained for analysis</em></span></p></td><td width=\'101’><p><span style=\'color: #ff0000;’><em>N4</em></span></p></td></tr></tbody></table><p><em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></p><p>In total, [<span style=\'color: #ff0000;’>insert here the number of reports</span>] reports were identified which fulfill the search criteria. Thereof, [<span style=\'color: #ff0000;’>insert here the number of reports</span>] reports were considered invalid due to <span style=\'color: #ff0000;’>[explain here why these reports should not be taken into consideration</span>] and [<span style=\'color: #ff0000;’>insert here the number of reports</span>] reports contained only limited information. The <span style=\'color: #ff0000;’>[insert here the number of reports included in the analysis</span>] reports from the NSH safety database included in the analysis are summarized in the table below.</p><p><span style=\'color: #ff0000;’>The following table(s) present the data by [e.g. date of reporting, country of reporting, gender, age categories, etc].</span></p><p><span style=\'color: #ff0000;’>The following can be used either as is or modified depending on the needs of the analysis:</span></p><p><span style=\'color: #ff0000;’>Graphs presenting the reporting rate of all cases of the issue under discussion to show trends in reporting rate and proportion of cases of interest versus total reporting with- drug of interest.</span></p><p><span style=\'color: #ff0000;’>Consider the following categories when presenting cases for analysis:</span></p><ul><li><span style=\'color: #ff0000;’>Solicited vs unsolicited cases</span></li><li><span style=\'color: #ff0000;’>Suspected vs not suspected events</span></li><li><span style=\'color: #ff0000;’>HCP versus non-HCP</span></li><li><span style=\'color: #ff0000;’>Organized by medical case definitions</span></li><li><span style=\'color: #ff0000;’>By gender, age group, country of origin, etc.</span></li></ul><p><span style=\'color: #ff0000;’>&nbsp;</span></p><p><span style=\'color: #ff0000;’>When presenting cases in a tabular format, consider to include a column \'comments’ or \'confounders’ instead of a description of each individual case in the text.</span></p><p><span style=\'color: #ff0000;’>&nbsp;</span></p><p><span style=\'color: #ff0000;’>&nbsp;</span></p><p><span style=\'color: #ff0000;’><em>Consider to use a table (see below).</em></span></p><table border=\'1’><tbody><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Number of cases since MA</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>X (HCP cases)</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Number of inadequately documented cases</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>x/X</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Serious (fatal)</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>x/X (Y)</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Time to onset</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>1<sup>st</sup> week: x/X</span></p><p><span style=\'color: #ff0000;’>1<sup>st</sup> month: y/X</span></p><p><span style=\'color: #ff0000;’>Unknown: Z/X</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Relevant medical history</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>x/X</span></p><p><span style=\'color: #ff0000;’>PT1 (x cases)</span></p><p><span style=\'color: #ff0000;’>PT2 (y cases)</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Relevant medical context</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>y/X</span></p><p><span style=\'color: #ff0000;’>PT1 (x cases)</span></p><p><span style=\'color: #ff0000;’>PT2 (y cases)</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Concomitant drugs for which this reaction is described</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>z/X</span></p><p><span style=\'color: #ff0000;’>DCI 1 (x cases)</span></p><p><span style=\'color: #ff0000;’>DCI 2 (y cases)</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Patient without relevant medical history, medical context or concomitant treatment</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>x/X</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Outcome</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>Recovered: x/X</span></p><p><span style=\'color: #ff0000;’>Not recovered: y/X</span></p><p><span style=\'color: #ff0000;’>Unknown: z/X</span></p></td></tr><tr><td width=\'229’><p><span style=\'color: #ff0000;’>Dechallenge/Rechallenge</span></p></td><td width=\'297’><p><span style=\'color: #ff0000;’>&nbsp;</span></p></td></tr></tbody></table><p><em>&nbsp;</em></p><p>&nbsp;</p><p>&nbsp;</p>'
  },
  {
    'title': 'Clinical data',
    'id': '5.2',
    'data': '<p><span style=\'color: #ff0000;’>Present data identified.</span></p>'
  },
  {
    'title': 'Literature',
    'id': '5.3',
    'data': '<p><span style=\'color: #ff0000;’>Use tables as much as possible.</span></p><p><span style=\'color: #ff0000;’>Consider whether inclusion of published meta-analyses of clinical trials would be advantageous to support your argumentation.</span></p><p>&nbsp;</p><p>The topic of <em>[<span style=\'color: #ff0000;’>specify here the matter under discussion</span>]</em> has been a subject of numerous publications. The most relevant articles that appeared between <em>[<span style=\'color: #ff0000;’>specify here the time period</span>]</em> are summarized in the table below.</p><p>or</p><p>The topic of <em>[<span style=\'color: #ff0000;’>specify here the matter under discussion</span>]</em> has been recently reviewed in detail by <span style=\'color: #ff0000;’>[<em>provide</em> </span><em><span style=\'color: #ff0000;’>name and reference</span>]</em> and the main aspects of this analysis are summarized in the table below.</p><p>or</p><p>Most of the publications reviewed address a somewhat different aspect of the matter under discussion, namely [<span style=\'color: #ff0000;’><em>indicated here what this non-relevant aspect is</em></span>] and will not be further discussed. However, several publications have been identified which are relevant and these are summarized in the table below.</p>'
  },
  {
    'title': 'Epidemiological studies',
    'id': '5.4',
    'data': ''
  },
  {
    'title': '[Others]',
    'id': '5.5',
    'data': '<p>This section could describe sources of data/information not covered by previous sections.</p><p><span style=\'color: #ff0000;’><em>Examples: </em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp; Health Authorities databases</em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp; Pharmacological class</em></span></p><p><span style=\'color: #ff0000;’><em>&nbsp;&nbsp; Non clinical data</em></span></p>'
  },
  {
    'title': 'Discussion',
    'id': '6',
    'data': '<p><span style=\'color: #ff0000;’><em>Analyze the data to make a strong case for your conclusions.</em></span></p><p><span style=\'color: #ff0000;’>&nbsp;</span></p><p><span style=\'color: #ff0000;’><em>State here the strong and weak points of your evaluation and any aspects of the analysis that may limit its scope or the generalizability of its results, such as patient population under investigation, period of time studied, underlying conditions, concomitant medication, strength of the evidence, etc.</em></span></p><p><span style=\'color: #ff0000;’>&nbsp;</span></p>'
  },
  {
    'title': 'Conclusion of the signal evaluation',
    'id': '7',
    'data': '<p><span style=\'color: #ff0000;’><em>Conclusions need to be supported by the information presented in the document and be derived from it in a transparent manner.</em></span></p><p>The purpose of this document is to <em>[<span style=\'color: #ff0000;’>insert purpose of the document as in Introduction &amp; Background sections</span></em>]. This has been achieved by a systematic review of information on <em>[<span style=\'color: #ff0000;’>state here the topic of your discussion</span>]</em> from the published literature, the NSH safety database, epidemiological evaluation / others.</p><ul><li>Based on this review, the following conclusions can be drawn:</li></ul><p><span style=\'color: #ff0000;’><em>Insert here the conclusion(s) and the main finding(s) supporting the conclusion</em></span></p><p>&nbsp;</p><p>We therefore conclude that [<span style=\'color: #ff0000;’><em>insert here the issue</em></span>] constitutes a new safety signal for <span style=\'color: #ff0000;’>product X.</span> &nbsp;</p><p>or</p><p>We therefore conclude that [<em><span style=\'color: #ff0000;’>insert here the issue</span> </em>] is refuted as a new safety signal for <span style=\'color: #ff0000;’>product X</span>. &nbsp;</p><p>&nbsp;</p><table border=\'1’><tbody><tr><td width=\'387’><p><strong>Recommendation&nbsp;</strong></p></td><td width=\'214’><p>&nbsp;</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal is recommended to be refuted</p><p>Or</p><p>The signal is recommended to be not refuted.</p><p>Or</p><p>There is inconclusive evidence as to refute the signal</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>&nbsp;</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal is a non-important potential risk&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal is a non-important identified risk&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal is an important potential risk&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal is an important identified risk&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal has a potential impact on the benefit-risk balance of the product&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The signal has the potential to constitute a substantial change * to the benefit-risk balance of the product</p><p>&nbsp; Yes&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;&nbsp;</p><p>* a new safety or efficacy finding that meets at least one of the following criteria:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; might lead to a new contra-indication for use;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or might lead to a potential removal of an approved indication;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an issue classified as Grade 1 priority</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any finding assessed as such by the Head Q&amp;PV (or delegate)</p><p>&nbsp;</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>A detailed benefit-risk assessment is needed&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No</p></td></tr><tr><td width=\'387’><p><strong>PV RM MD:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p></td><td width=\'214’><p>Date:</p></td></tr><tr><td width=\'387’><p>Date:</p></td><td width=\'214’><p>&nbsp;</p></td></tr><tr><td width=\'387’><p><strong>&nbsp;</strong></p></td><td width=\'214’><p>&nbsp;</p></td></tr><tr><td width=\'387’><p><strong>Approvers:</strong></p></td><td width=\'214’><p>&nbsp;</p></td></tr><tr><td colspan=\'2’ width=\'601’><p>The above mentioned recommendation are approved.</p><p>The matter should/should not be referred to the Product Safety Council.</p></td></tr><tr><td width=\'387’><p>EU QPPV (where applicable)</p></td><td width=\'214’><p>&nbsp;</p></td></tr><tr><td width=\'387’><p>Head Global&nbsp; PV Risk Minimisation</p></td><td width=\'214’><p style=\'padding-left: 30px;’>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>'
  },
  {
    'title': 'References',
    'id': '8',
    'data': 'Provide here a numerical list of the references quoted in the document. Limit your references in the document to the most relevant ones. Be aware that all literature references quoted will have to be made available as .pdf files.In order to prevent / limit delays in processing of the final document, while waiting for the .pdf files of the references, request these well in advance.'
  },
  {
    'title': 'Appendices',
    'id': '9',
    'data': ''
  }
];
